First Trust Advisors LP lifted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 12.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 932,168 shares of the company's stock after acquiring an additional 102,847 shares during the quarter. First Trust Advisors LP owned 0.20% of GE HealthCare Technologies worth $70,006,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in the company. HUB Investment Partners LLC acquired a new stake in GE HealthCare Technologies in the third quarter valued at about $219,000. Barclays PLC increased its position in GE HealthCare Technologies by 10.4% during the 3rd quarter. Barclays PLC now owns 1,753,314 shares of the company's stock worth $131,674,000 after purchasing an additional 164,821 shares during the period. Advisory Alpha LLC purchased a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $265,000. Viawealth LLC raised its stake in shares of GE HealthCare Technologies by 5.6% during the 3rd quarter. Viawealth LLC now owns 4,669 shares of the company's stock worth $351,000 after buying an additional 246 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of GE HealthCare Technologies by 8.9% in the 3rd quarter. Dimensional Fund Advisors LP now owns 5,362,717 shares of the company's stock valued at $402,647,000 after buying an additional 438,439 shares during the period. Institutional investors and hedge funds own 82.06% of the company's stock.
Analyst Upgrades and Downgrades
GEHC has been the topic of a number of analyst reports. Barclays lifted their price target on GE HealthCare Technologies from $86.00 to $87.00 and gave the company an "equal weight" rating in a research note on Friday, February 6th. BTIG Research raised their target price on GE HealthCare Technologies from $87.00 to $91.00 and gave the company a "buy" rating in a report on Wednesday, February 4th. Stifel Nicolaus boosted their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a "buy" rating in a research report on Wednesday, February 4th. Citigroup upped their price target on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a "neutral" rating in a research note on Thursday, December 11th. Finally, Morgan Stanley increased their price target on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the company an "equal weight" rating in a report on Wednesday, February 4th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies presently has an average rating of "Hold" and a consensus price target of $92.50.
View Our Latest Report on GEHC
GE HealthCare Technologies Stock Performance
GEHC opened at $72.73 on Wednesday. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $89.77. The stock has a market cap of $33.15 billion, a P/E ratio of 15.95, a P/E/G ratio of 1.66 and a beta of 1.03. The stock's 50 day simple moving average is $81.44 and its 200 day simple moving average is $78.61. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to analysts' expectations of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.GE HealthCare Technologies's revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.
GE HealthCare Technologies Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies's payout ratio is 3.07%.
About GE HealthCare Technologies
(
Free Report)
GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.